Skip to main content

Table 1 Participants’ characteristics

From: Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings

  Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 Group 7 Group 8 Total
N = 61
Participants
 Public 10 7 7 8      32
 Patients      9 7 8 5 29
Location
 Québec City 10 7    9 7    33
 Montréal    7 8    8 5 28
Gender
 Female 10   7   9   8   34
 Male   7   8   7   5 27
Age groups
 25 or less 0 2 2 1 0 0 0 0 5
 26 to 35 4 0 2 2 0 0 0 0 8
 36 to 50 1 3 1 3 5 0 4 0 17
 50 or more 5 2 2 2 4 7 4 5 31
Education
 High school 7 4 4 5 3 3 3 1 30
 College 3 3 3 3 6 4 5 4 31